Temasek Holdings’s Aimmune Therapeutics AIMT Stock Holding History

Temasek Holdings’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-333,444	Closed	-$11.5M	–	81
2020 Q3	$11.5M	Buy	+333,444	New	+$7.1M	0.06%	58

Temasek Holdings's AIMT Position: Q4 2020 in Review

Temasek Holdings sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 333,444 shares — an estimated $11.5M sold.

Temasek Holdings first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $11.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Temasek Holdings reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Temasek Holdings sold 333,444 Aimmune Therapeutics shares in Q4 2020, an estimated $11.5M.
Temasek Holdings first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Temasek Holdings's Aimmune Therapeutics position peaked at $11.5M in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Temasek Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.